Billionaires Are Dumping Nvidia and Buying This Unstoppable AI Stock Under $10 Hand Over Fist

Lantronix reported Q3 FY2026 revenue of $30.18 million, up 5.9% year over year, with Embedded IoT Solutions revenue rising 22% and non-GAAP EPS of $0.04. Wall Street sentiment is constructive, with one Strong Buy and three Buy ratings and a $9.12 average target versus the $6.36 share price, while management raised FY2026 drone revenue guidance to $10 million-$14 million and expects drone revenue to roughly double in FY2027. Offseting the positive backdrop, the company announced up to $30 million of equity dilution against a $253 million market cap and remains GAAP unprofitable.

Analysis

This is less a pure AI rotation trade than a capital-allocation re-rating of the edge-compute supply chain. If investors are indeed stepping down from mega-cap AI into sub-$500M names, the first winners are the companies that translate policy into backlog fastest: NDAA-compliant embedded hardware, secure networking, and systems integrators tied to defense procurement. That makes LTRX more of a “picks-and-shovels” beneficiary than a drone pure play, while RCAT should act as a sentiment amplifier rather than the cleaner operating leverage story.

The second-order effect is that any incremental defense budget or DJI restriction does not just help end-demand; it shifts bargaining power toward U.S.-certified component vendors. In that setup, the scarce asset is not AI inference software but trusted hardware qualification and integration cycles, which can re-rate revenue visibility even before revenue inflects materially. The market is likely underestimating how quickly a few design wins can matter at this market cap, but also how fragile the narrative is if one procurement slip or one financing event resets the multiple.

The contrarian issue is timing: this may be a 6-12 month story, not a 6-12 day story. The stock can continue to grind higher on guidance and positioning, but the real catalyst is conversion from “engagements” to repeatable program revenue, and that usually lags headlines. Meanwhile, dilution risk is not just a balance-sheet footnote; for a company this size, any equity raise can cap upside by forcing the market to underwrite growth with a wider cost of capital and a lower terminal multiple.

Consensus may also be overpaying for the defense angle while underpricing execution risk in the broader industrial IoT business. If the drone line doubles but the legacy segments only grow low-single digits, the market may keep valuing this as a financing story rather than a durable growth compounder. The cleaner tell will be whether management can sustain double-digit FY2027 growth without another material equity issuance; if yes, the rerating has room, if not, upside gets clipped quickly.

Key Decisions for Investors

• Long LTRX on a 3-6 month horizon only if it holds post-offering support; target a move toward the analyst range with a tight stop below the financing overhang, because dilution is the main factor that can compress the multiple quickly.
• Pair long LTRX / short NVDA as a relative-value rotation trade for 1-3 months, betting that incremental AI capital moves down the market-cap spectrum; the upside is cleaner if small-cap defense names continue to attract fresh flows while mega-cap leadership pauses.
• Use RCAT as a higher-beta expression of the same theme only via options, not common stock, since it should outperform on sentiment spikes but can give back gains sharply on any procurement delay; favor call spreads over outright longs.
• Avoid chasing LTRX after headline-driven gaps; wait for a pullback or a confirmation print showing revenue conversion, because the risk/reward improves materially if the market digests the dilution first.
• If buying LTRX common, size it as a catalyst trade, not a core holding: 0.5%-1.0% portfolio risk with a 2:1 to 3:1 upside/downside framing, since the stock can rerate fast but remains vulnerable to capital raises and lumpy federal orders.